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Abstract: Maintaining normal calciwn levels within the body (8.5-10 mg elL 1) requires the action of two 
hormones in particular: Parathyroid Hormone (PTH) and calcitonin (hltp://www.bloodbookcomlranges.htrnl). 
In lower calciwn levels, FIR is released and works in such a way as to increase the calciwn back to the normal 
range. Calcitonin acts exactly in the inverse way by targeting osteoclasts and osteoblasts. A somewhat 
constant amollllt of calciwn is lost from the body through fecal excretion. In the gut, absorption and secretion 
of calciwn and phosphate occurs, depending on the free ionized calciwn in the extracellular fluid. The amollllt 
of calciwn in the extracellular fluid also influences excretion of calciwn in the renal system. The largest pool of 
calciwn is fOlllld in bone which is essential in calciwn homeostasis. This is because through bone remodelling, 
calciwn may be taken up from the extracellular fluid or given up to the extracellular fluid depending on the 
presence of hormones in a process kno"\iVll as osteolytic osteolysis. The processes mentioned before are 
mediated through PTH, calcitonin and 1,25-dihydroxycholecalciferoL 
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INTRODUCTION 
Calciwn has several important fllllctions in the body 
including enzymatic regulation (e.g., cahnodulin), 
neuromuscular fllllction, blood coagulation and hormone 
secretion. The free ionized calciwn levels making up 48% 
of calciwn in the blood, fluctuates and hormones act 
on this form on calciwn to restore homeostasis. About 
99% of calciwn in the body is fOlllld in the form of 
hydroxyapatite crystals which make up the inorganic 
component of bone. Trabecular bone is important to 
calciwn twnover in bone as it presents with a greater 
surface area and so it is highly accessible. Bone 
mineralisation and resorption are regulated by PTR and 
vitamin D in contrast to calcitonin which stimulates bone 
formation only (Blair e/ aI., 2007). 
PARATHYROID HORMONE ACTIONS AND 
CALCIUM REGULATION 
PTR, secreted by chief cells in the parathyroid 
glands is essential ill regulating calciwn and 
phosphate levels in the body by influencing intestinal 
absorption, renal excretion as well as ion exchange 
between the extracellular fluid and bone fluid across the 
osteocytic membrane. Maximal PTR secretion occurs 
at calciwn levels <3.5 mg dL -1 and is inhibited at levels 
>5.5 mg dL -1. In low calciwn levels, adenylyl cyclase is 
activated causing an increase in intracellular cyclic A1.1P. 
Phospholipase C is inhibited causing a decrease in 
inositol triphosphate and in twn, a decrease in 
intracellular calciwn. These processes stimulate high 
levels of PTR secretion. 
PTR causes bone absorption of calciwn and 
phosphate from bone by two ways; activating osteocytes 
and osteoblasts within minutes to hours and stimulating 
haematopoeitic tissue for osteoclast proliferation. After a 
few days, secondary signals activate the fully matured 
osteoclasts to increase reabsorption of bone itself and not 
selectively taking up calciwn and phosphate ions from the 
bone reservoir. Absorption of salts takes place readily; 
since they are extremely small and have a high surface 
area exposed to extracellular fluid and blood (about 5% of 
the cardiac output is distributed to bone). PTR promotes 
the formation of vitamin D3 in the kidneys and therefore, 
indirectly promotes calciwn absorption through the gut. 
PTR prevents calciwn excretion in the distal convoluted 
tubules in the kidneys by stimulating its reabsorption 
whose actions are mediated via the PTR receptor. 
Mutations in the PTR receptor cause problems such 
as hypocalcemia and Jansen's metaphyseal 
chondrodysplasia amongst others, showing how 
important PTR intracellular mechanisms are to calciwn 
homeostasis. 
PTR also increases inorganic phosphate elimination 
by the kidueys by inhibiting its reabsorption in the distal 
tubules of the kidueys (Pettway e/ aI., 2007). The red lines 
indicate feedback inhibition of parathyroid hormone and 
1 a-hydroxylase whilst the green positive sign and red 
negative sign show enhancement and inhibition of 
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Fig. 1: The main processes ofvitaminD synthesis, metabolism and its effects on the intestine and bone in conjunction 
withPTH 
1 a-hydroxylase. Receptor activator for nuclear kB 
(RANK) stimulates osteoclastic activity in bone (Fig. I) 
(http://www .j ci. org/articles/view 129449/figure/3). 
Continued FIR stimulation for months results in 
weakened bones, thus osteoblasts are activated 
simultaneously in an attempt to mineralise bone. Since, 
bone is a buffer-reservoir of calcium and contains about 
1 CO) times as much calcium as the extracellular fluid, the 
effect of weakened bones is not immediately observed. 
However, in severe calcium deficiency or prolonged FIR 
secretion; commonly caused by vitamin D deficiency in 
children and the elderly. leading to secondary 
hyperparathyroidism, bone cavities containing 
multinucleated osteoclasts can be found after several 
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months. The mitochondria of tissues such as the 
intestines are rich in calcium and also aid the buffering 
system as exchange across to the extracellular fluid occurs 
to maintain constant calcium levels (Pettway et al., 2007). 
IDIOPATIllC HYPERCALCIURIA AND CALCIUM 
SENSING RECEPTORS 
In a study by Worcester and Coe (2008). it was found 
that increased calcium bone loss results in Idiopathic 
Hypercalciuria (IH) which in twn causes kidney stones. 
Usually, in bones which are no longer growing in 
healthy non-pregnant adults, calcium absorption is 
matched by renal excretion. This is sufficient for the 
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maintenance of bone lIDless there is a pathological 
reason for excess excretion (i.e., >250 mg day-l in females 
and >300 mg day-l in males in urine). IH was fOlllld to be 
a complex polygenic trait which is largely dependent on 
the diet. It was fOlllld that a low calcilllll diet results in a 
negative calciwn balance despite increased intestinal 
uptake and decreased renal excretion in rH. The continual 
loss of calciwn from resorption is a detriment to the 
skeletal system and growth. This condition also causes an 
increase in VDR receptors however, there is no significant 
increase in 1,25-(OH)2D3 which could point to 
increased effectiveness of 1,25-(OH)2D3 due to 
increased receptors. Calciwn Sensing Receptors (CaSR) 
responsive to 1,25-(OH)2D3 and located in parathyroid, 
renal, bone and intestinal tissues in these patients were 
fOlIDd to be mutated having a gain in flIDction. This 
abnormality along with VDR polymorphisms is considered 
to be a contributing factor to the disease. PTH levels in 
these patients were normal or slightly low however, PTH 
seems to be suppressed therefore causing less calcilllll 
reabsorption from the late distal and collecting tubules. 
INTRACELLULARPTHMEDIATEDMECHANISMS 
Cyclic AJ\.1P seems to mediate most ofPTH's effects 
by a secondary messenger mechanism since, it increases 
rapidly in its effecter cells including osteocytes and 
osteoclasts. Osteoclastic secretion of enzymes and 
acids which cause bone resorption and formation of 
1.25-(OH),D,maybe dependent on cAMP mechanisms. A 
slight decrease in calcilllll detected by the CaSRs in the 
parathyroid glands causes an immediate increase in 
secretion of PTH and the opposite occurs in an increase 
in calciwn sennn concentration (Guyton and Hall, 2005). 
Osteoclasts also possess a calciwn sensing flIDction 
when a fluctuation of as much as 8-20 mM is detected, 
hydroxyapatite dissolution occurs by stimulated 
osteoclasts. The Ryanodine Receptor molecule (RyR) 
seems to aid osteoclast regulation when it comes to 
calciwn influx and efflux and possibly calcilllll sensing, 
however its role remains llllclear (Blair et al., 2007). 
OPGIRANK!RANK-L SYSTEM AND BONE 
REMODELLING 
A protein belonging to the TlllllOur Necrosis Factor 
superfamily, RANK-L (receptor activator nuclear factor kB 
ligand), its receptor RANK (receptor activator nuclear 
factor kB) and Osteoprotegerin (OPG) seem to playa key 
role in bone resorption. RANK is a receptor fOlllld on 
osteoclasts, RANK-L is transcribed by osteoblasts, bone 
marrow stromal cells and T -lymphocytes and OPG is 
expressed on osteoblasts. PTH and vitamin D seem to be 
involved in OPG and RANK-L regulation and expression 
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on cells, consequently regulating bone remodelling. 
Remodelling occurs in steps including activation, 
resorption, reversal and formation. Although, OPG 
nwnbers increase in people >70 years of age, the 
OPGIRANK!RANK-L mechanisms involved in preventing 
bone loss deem to be insufficient. PTH in the elderly is 
increased resulting in increased calciwn in the extra- and 
intra-cellular fluid. 
However, these patients are usually suffering 
from vitamin D hypovitaminosis due to a reduction in 
amollllt of 7 -dehydrocholesterol in the skin required 
for vitamin D synthesis as well as more time spent 
indoors with insufficient exposure to UV light and low 
vitamin D (and calcium) intake in the diet (Kearns e/ 01 .• 
2008). 
CALCITONIN REGULATING CALCIUM AND 
PHOSPHATE LEVELS 
Calcitonin has the opposite effects of PTH as it 
depresses calciwn concentration in the extracellular fluid. 
It is secreted by the parafollicular cells (C cells) in the 
follicles of the thyroid gland in response to increased 
calciwn levels. Therefore, it inhibits the absorptive action 
of osteoclasts as well as osteolytic activities and 
amorphous calciwn phosphate exchange across the 
osteocytic membrane. Consequently, it deposits excess 
calcilllll in the form of calcilllll salts. A long term effect of 
calcitonin is to decrease osteoclast formation resulting in 
decreased osteoblast nlllllbers and it exchanges calcilllll 
despite laying down mineral salts on the bone matrix. 
However, calcitonin has a limited effect on calcilllll 
homeostasis, since studies have shown that following a 
thyroidectomy, the calcilllll ion concentration is not 
significantly changed. The rates of absorption and 
deposition are very low in hwnans, thus decreased 
absorption due to calcitonin does not impact extracellular 
calciwn concentration lIDless a pathological condition is 
present such as Paget's disease in which osteoclasts are 
highly activated. Also as calcitonin increases, PTH 
decreases and vice versa (Davey et al., 2008). 
CONCLUSION 
Both PTH and calcitonin work in influencing calciwn 
and phosphate levels and are released depending on the 
activation of the calciwn sensitive cells. These hormones 
affect each other as well as vitamin D and maintain 
calciwn within a narrow range. A loss of control in calcilllll 
levels is detrimental as can be seen in conditions such as 
idiopathic hypercalciuria, primary hyperparathyroidism, 
pseudohypoparathyroidism, hypercalcemia due to 
malignancy and Jansen's metaphyseal chondrodysplasia 
where a PTH receptor defect is involved. 
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